US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

39.590
-0.610-1.52%

Trading Mar 28 15:12 ET

6.22BMarket Cap263.93P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics Q4 2024 Earnings Date

Currency：USDMar 3, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	100.67M	108.19M	+7.51M
Beat Est.	+128.95%	+146.04%	+7.46%
EPS	0.09	0.15	+0.06
Beat Est.	+192.09%	+250.00%	+63.04%

Analyst Rating

Buy

Mar 4, 2025

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 130.245M	--
--	2025/Q1	-- / 117.073M	--
Mar 3, 2025	2024/Q4	108.185M / 100.674M	--
Nov 4, 2024	2024/Q3	83.879M / 81.705M	--
Aug 6, 2024	2024/Q2	73.466M / 65.893M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 130.245M--

--2025/Q1-- / 117.073M--

Mar 3, 20252024/Q4108.185M / 100.674M--

Nov 4, 20242024/Q383.879M / 81.705M--

Aug 6, 20242024/Q273.466M / 65.893M--

Unlock Free Earnings Estimates

Open Account

TG Therapeutics Earnings Reports

TG Therapeutics | 10-K: FY2024 Annual Report

Mar 3 16:03 ET

TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3 07:19 ET

TG Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:38 ET

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance

Nov 4, 2024 07:24 ET

Market Insights

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Collegium Pharmaceutical

COLL

+0.15%